Information  X 
Enter a valid email address

Hammerson PLC (HMSO)

  Print          Annual reports

Wednesday 08 December, 2021

Hammerson PLC

Transaction in Own Shares

RNS Number : 8914U
Hammerson PLC
08 December 2021

8 December 2021


Hammerson plc (the "Company")



Hammerson plc (the "Company") announces that, in accordance with the terms of its share repurchase programme announced on 6 December 2021, the Company purchased the following number of its ordinary shares of 5 pence each from Morgan Stanley & Co. International plc. Such purchase was effected pursuant to instructions issued by the Company on 6 December 2021.


Date of purchase:

7 December 2021

Number of ordinary shares purchased:


Highest price paid per share (pence):


Lowest price paid per share (pence):


Volume weighted average price paid per share (pence):



The Company intends to hold the purchased shares in treasury.


Since 6 December 2021, the Company has purchased 840,074 shares at a cost (including dealing and associated costs) of £274,579.30.   Following the purchase of these shares, the Company holds 840,074 of its ordinary shares in treasury and has 4,418,617,087 ordinary shares in issue (excluding treasury shares). This number of shares reflects the additional 215,712,923 new ordinary shares of 5 pence each issued by the Company on 7 December 2021 to satisfy the number of valid elections received to participate in the Enhanced Scrip Dividend Alternative.


A full breakdown of the individual trades made by Morgan Stanley & Co. International plc on behalf of the Company as part of the share repurchase programme is attached to this document.


This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.




Josh Warren

Director of Strategy and Investor Relations

Tel: +44 20 7887 1053

[email protected]


The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t